Paraoxonase-1 and clopidogrel efficacy

被引：19
|
作者：
Cuisset, Thomas [1 ,2 ]
Morange, Pierre-Emmanuel [2 ]
Quilici, Jacques [1 ]
Bonnet, Jean Louis [1 ]
Gachet, Christian [3 ]
Alessi, Marie-Christine [2 ]
机构：
[1] Univ Hosp La Timone, Dept Cardiol, Marseille, France
[2] Fac Med Marseille, INSERM, U626, F-13385 Marseille, France
[3] Univ Strasbourg, Etab Francais du Sang Alsace, INSERM, UMR S949, Strasbourg, France
来源：
NATURE MEDICINE | 2011年 / 17卷 / 09期
关键词：
POLYMORPHISMS;
D O I：
10.1038/nm.2367
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1039 / 1039
页数：1
相关论文
共 50 条
  • [41] Paraoxonase-1 genetic polymorphisms in organophosphate metabolism
    Dardiotis, Efthimios
    Aloizou, Athina-Maria
    Siokas, Vasileios
    Tsouris, Zisis
    Rikos, Dimitrios
    Marogianni, Chrysa
    Aschner, Michael
    Kovatsi, Leda
    Bogdanos, Dimitrios P.
    Tsatsakis, Aristidis
    TOXICOLOGY, 2019, 411 : 24 - 31
  • [42] The Potential Importance of Paraoxonase-1 in Surgical Patients
    Vekic, Jelena
    Kotur-Stevuljevic, Jelena
    JOURNAL OF INVESTIGATIVE SURGERY, 2021, 34 (02) : 225 - 226
  • [43] EFFECTS OF METFORMIN IN PARAOXONASE-1 DEFICIENT MICE
    Fort, I.
    Riera-Borrull, M.
    Rodriguez-Gallego, E.
    Hernandez-Aguilera, A.
    Luciano, F.
    Fernandez-Arroyo, S.
    Abengochea, A.
    Marine, R.
    Guirro, M.
    Camps, J.
    Garcia Heredia, A.
    ATHEROSCLEROSIS, 2014, 235 (02) : E193 - E193
  • [44] Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates
    Bosak, Anita
    Bavec, Aljosa
    Konte, Tilen
    Sinko, Goran
    Kovarik, Zrinka
    Golicnik, Marko
    MOLECULES, 2020, 25 (01):
  • [45] Paraoxonase-1 (PON1) Activity And PON1 Polymorphisms Have No Effect On Platelet Reactivity In Patients Treated With Clopidogrel
    Dery, Jean-Pierre P.
    Khalil, Abdelouahed
    Dery, Ugo
    Roy, Melanie
    Tricoci, Pierluigi
    Becker, Richard
    Rinfret, Stephane
    Larose, Eric
    Barbeau, Gerald
    DeLarochelliere, Rober
    Rodes-Cabau, Josep
    Bertrand, Olivier F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B40 - B40
  • [46] EVALUATION OF PARAOXONASE-1 GENE POLYMORPHISM AND SERUM PARAOXONASE ACTIVITY AS A CARDIOVASCULAR RISK
    Bayrak, T.
    Deniz, A.
    Tokgozoglu, L.
    Yavuz, B.
    Demirpence, E.
    Bayrak, A.
    Kilinc, K.
    Salanci, B.
    Alikasifoglu, M.
    Tuncbilek, E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 106 - 106
  • [47] Paraoxonase-1 activity affects the clopidogrel response in CYP2C19 loss-of-function carriers
    Nishio, Ryo
    Shinke, Toshiro
    Otake, Hiromasa
    Nakagawa, Masayuki
    Inoue, Takumi
    Hariki, Hirotoshi
    Osue, Tsuyoshi
    Taniguchi, Yu
    Iwasaki, Masamichi
    Hiranuma, Noritoshi
    Konishi, Akihide
    Kinutani, Hiroto
    Kuroda, Masaru
    Hirata, Ken-Ichi
    THROMBOSIS RESEARCH, 2013, 132 (05) : 558 - 564
  • [48] Paraoxonase-1 promoter polymorphism C-107T and serum apolipoprotein AI interact to modulate serum paraoxonase-1 status
    James, RW
    Kalix, B
    Bioletto, S
    Brulhart-Meynet, MC
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (06): : 441 - 446
  • [49] Structure/function analyses of human paraoxonase-1 mutants
    Yeung, D
    Josse, D
    Kirby, S
    Duryea, C
    Lenz, D
    Cerasoli, D
    FASEB JOURNAL, 2004, 18 (08): : C144 - C144
  • [50] Oxidative stress and phenotype frequencies of paraoxonase-1 in teratozoospermia
    Ozer, Omer Faruk
    Akbulut, Habib
    Guler, Eray Metin
    Caglar, Hifa Gulru
    Gevher, Fatih
    Koktasoglu, Fatmanur
    Selek, Sahabettin
    ANDROLOGIA, 2019, 51 (08)
12345